Concepedia

Author

Seppo W. Langer

RigshospitaletORCID

Also Known As

Elizaveta Tabaksblat, Jonathan S. Gootenberg, Langer S, Langer SW, Langer, S. W., Langer, S.W., Langer, SW, Mark Agulnik, S Langer, S W Langer

322

Publications

6.3K

Citations

39

H-Index

104

Concepts

All Affiliations

RigshospitaletUniversity of CopenhagenCopenhagen University HospitalOdense University HospitalHaukeland University Hospital
SW

About

Seppo W. Langer is an author at Rigshospitalet specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

24

38

2.9K

2

Health Sciences

11

11

698

3

Education

1

1

28

4

Engineering

1

1

22

5

Natural Sciences

1

1

16

Seppo W. Langer

×

94

Publications

5.1K

Citations

37

H-Index

YearCitations

Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study

Staffan Welin, Seppo W. Langer, Lene Weber Vestermark,

Annals of Oncology

2012

1K

Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study

Fiona Blackhall, Kevin Jao, Laurent Greillier,

Journal of Thoracic Oncology

2021

239

Head-to-Head Comparison of <sup>64</sup>Cu-DOTATATE and <sup>68</sup>Ga-DOTATOC PET/CT: A Prospective Study of 59 Patients with Neuroendocrine Tumors

Camilla Bardram Johnbeck, Ulrich Knigge, Annika Loft,

Journal of Nuclear Medicine

2016

226

A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis

Barbara Malene Fischer, Jann Mortensen, Seppo W. Langer,

Annals of Oncology

2006

172

Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies

H.T. Mouridsen, Seppo W. Langer, Jan Buter,

Annals of Oncology

2006

159

Safety and feasibility of a combined exercise intervention for inoperable lung cancer patients undergoing chemotherapy: A pilot study

Morten Quist, Mikael Rørth, Seppo W. Langer,

Lung Cancer

2011

143

<sup>64</sup>Cu-DOTATATE PET for Neuroendocrine Tumors: A Prospective Head-to-Head Comparison with <sup>111</sup>In-DTPA-Octreotide in 112 Patients

Andreas Pfeifer, Ulrich Knigge, Tina Binderup,

Journal of Nuclear Medicine

2015

137

High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial

Bjørn Henning Grønberg, Kristin Toftaker Killingberg, Øystein Fløtten,

The Lancet Oncology

2021

129

The Impact of a Multidimensional Exercise Intervention on Physical and Functional Capacity, Anxiety, and Depression in Patients With Advanced-Stage Lung Cancer Undergoing Chemotherapy

Morten Quist, Lis Adamsen, Mikael Rørth,

Integrative Cancer Therapies

2015

117

Treatment of anthracycline extravasation with dexrazoxane.

Seppo W. Langer, Maxwell Sehested, Jensen Pb

PubMed

2000

112

Page 1